Paul Blundell is the President of Organix, a Symeres company, with a Ph.D. in Chemistry from Texas A&M University. He has deep expertise in medicinal chemistry, specifically in the tropane, lipid, and opioid fields, with over 24 publications and 12 patents. Colleagues describe him as an "excellent manager and chemist" with a commitment to transparency.
Beyond his extensive scientific career, Paul has a stated interest in the Royal Air Force (RAF), indicating a potential passion for aviation or military history. He appears focused on professional endeavors with limited publicly shared personal information.
Unique fact: Paul has a particular research interest in anti-tumor agents that are activated by light.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.